Aegerion Pharmaceuticals Inc. (AEGR) Drops 5.87% on January 19

Equities Staff |

Aegerion Pharmaceuticals Inc. (AEGR) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 5.87% to $7.06, a loss of $-0.44 per share. Starting at an opening price of $7.42 a share, the stock traded between $6.91 and $7.63 over the course of the trading day. Volume was 262,102 shares over 2,215 trades, against an average daily volume of 768,639 shares and a total float of 28.94 million.

The losses send Aegerion Pharmaceuticals Inc. down to a market cap of $204.3 million. In the last year, Aegerion Pharmaceuticals Inc. has traded between $28.97 and $6.82, and its 50-day SMA is currently $10.00 and 200-day SMA is $16.65.

Aegerion Pharmaceuticals Inc is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.

Aegerion Pharmaceuticals Inc. is based out of Cambridge, MA and has some 307 employees. Its CEO is Mary T. Szela.

For a complete fundamental analysis analysis of Aegerion Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for AEGR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth


VOIP-PAL COM Inc is a development stage company. The Company is engaged in broadband Voice-over-Internet Protocol ("VoIP") market with the ownership and continuing development of a portfolio of VoIP Patents.

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…